disaster
DR Congo: Two new candidate vaccines to join Ebola trial as treatment research advances
. The recommendation marks the first time vaccines specifically designed to protect against Bundibugyo virus, the virus responsible for the current outbreak, will be evaluated during an outbreak of the disease. The two vaccine candidates are ChAdOx1, developed by the University o...

